Valderilio Feijó Azevedo
Valderilio Feijó Azevedo is an Associate Professor of Rheumatology and the former head of the Rheumatology Unit, Hospital de Clínicas, Federal University of Paraná (FPR), Brazil. Since 2009, he has been the owner and principal investigator of EDUMED Health Research and Education and EDUMED Biotech. His major research interests include clinical trials, regulatory advances in biologics therapies, spondyloarthritis, new treatment strategies for autoimmune diseases, biologics and biosimilars, and translational research in spondyloarthritis. Dr. Azevedo has authored several publications in the field. He is a member of the Brazilian Committee of Psoriatic Arthritis and coordinator of the Brazilian Committee of Biotechnology at the Brazilian Society of Rheumatology. He is also a member of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), European Scleroderma Trials and Research (EUSTAR), and a former member of the Assessment of SpondyloArthritis international Society (ASAS). Dr. Azevedo is an executive board member of Americas Health Foundation, Washington, DC. He has worked on projects on pharmacovigilance of biologics and biosimilars and spondyloarthritis and has been the coordinator of the Latin American Forum on Biosimilars (FLAB) since 2010. He is also an advisory board member of the Alliance for Safe Biologic Medicines, Washington, DC.